课题基金 / 基金详情

项目摘要

项目成果

TERRY L. SHEPPARD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Support is requested for a Keystone Symposia conference entitled Metabolic and Molecular Mechanisms of NAFLD/NASH, organized by Drs. James Trevaskis, Jacquelyn Maher and Quentin Anstee. The conference will be held in Banff, Alberta, Canada from March 19 - 23, 2023. Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) represents the hepatic manifestation of the metabolic syndrome and is emerging as a key driver of morbidity and mortality, particularly when present in the context of severe liver fibrosis. The histological hallmarks of NASH including steatosis, lobular inflammation and hepatocyte ballooning are well-characterized; however, while it is widely recognized that NASH is a progressive disease, the pathogenic and molecular mechanisms that initiate and drive NASH remain largely unknown. Therefore, this conference was designed to bring together a broad group of scientific and clinical researchers to highlight and discuss the current evidence exploring the key biological processes involved in NASH and liver fibrosis. This conference program will cover topics such as insulin resistance, hepatocyte lipid management/lipotoxicity and inflammation in the context of steatosis and NASH. Furthermore, advances in our understanding of the molecular and genetic regulation of NAFLD/NASH and the progression to liver fibrosis will also be highlighted. Finally, as NASH is an unmet medical need, this program will integrate the earlier fundamental biology discussion with updates on clinical progress of therapeutic agents, and combinations of agents, for the treatment of NASH and liver fibrosis. Finally, this conference will be held jointly with Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies. The joint conference will focus on the key cellular drivers and mediators of fibrosis in organs beyond the liver and allows for cross-functional discussion and deeper understanding of pathobiology of fibrotic disease. Participants from both conferences will have the opportunity to network through shared sessions, mealtimes, and evening poster sessions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
  • 批准号:
    10682118
  • 项目类别:
  • 资助金额:
    $1.53万
  • 财政年份:
    2023
  • 负责人:
    TERRY L. SHEPPARD
  • 依托单位:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
  • 批准号:
    10540260
  • 项目类别:
  • 资助金额:
    $1.0万
  • 财政年份:
    2023
  • 负责人:
    TERRY L. SHEPPARD
  • 依托单位:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
  • 批准号:
    10753451
  • 项目类别:
  • 资助金额:
    $0.6万
  • 财政年份:
    2023
  • 负责人:
    TERRY L. SHEPPARD
  • 依托单位:
Vaccinology During and After COVID-19
  • 批准号:
    10753782
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    2023
  • 负责人:
    TERRY L. SHEPPARD
  • 依托单位:
海外基金